DFFVX | UBVLX | DFFVX / UBVLX | |
Total Expense Ratio | 0.29 | 0.90 | 32% |
Annual Report Gross Expense Ratio | 0.30 | 0.95 | 32% |
Fund Existence | 25 years | 26 years | - |
Gain YTD | -14.553 | -11.879 | 123% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.3B | 8.8B | 128% |
Annual Yield % from dividends | 1.63 | 1.90 | 86% |
Returns for 1 year | -3.30 | -4.49 | 73% |
Returns for 3 years | 1.74 | -9.86 | -18% |
Returns for 5 years | 105.39 | 102.80 | 103% |
Returns for 10 years | 33.70 | 39.84 | 85% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETIHX | 29.46 | 0.40 | +1.38% |
Eventide Healthcare & Life Sciences I | |||
FMVQX | 49.50 | 0.52 | +1.06% |
Nuveen Mid Cap Value 1 R6 | |||
HAOYX | 20.00 | 0.17 | +0.86% |
Hartford International Opportunities Y | |||
QSERX | 15.07 | 0.10 | +0.67% |
AQR Small Cap Multi-Style R6 | |||
CNPFX | 57.25 | 0.30 | +0.53% |
American Funds New Perspective 529F |